Anzeige
Mehr »
Donnerstag, 08.01.2026 - Börsentäglich über 12.000 News
Steht diese NASDAQ-Biotech-Aktie jetzt vor einer seltenen Kaufgelegenheit?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41HQ7 | ISIN: US80512Q5018 | Ticker-Symbol: 80W
NASDAQ
07.01.26 | 22:00
1,560 US-Dollar
0,00 % 0,000
Branche
Chemie
Aktienmarkt
Sonstige
1-Jahres-Chart
N2OFF INC Chart 1 Jahr
5-Tage-Chart
N2OFF INC 5-Tage-Chart

Aktuelle News zur N2OFF Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoN2OFF treibt europäisches Solarportfolio mit Meilenstein bei deutschem Projekt voran3
MoN2OFF advances European solar portfolio with key German project milestone2
MoN2OFF Inc.: N2OFF Advances $340,000 Payment to Gain Better Terms in Flag Solar Energy Initiative, Reflecting Approximately an Additional $1.7 Million in Project Profit Stake2
29.12.25N2OFF advances European solar portfolio with key milestones in Germany, Italy1
29.12.25N2OFF Inc.: N2OFF Accelerates European Renewable Energy Momentum with Major De-Risking Milestones and Approximately $1.69 Million Value Unlock in Germany and Italy382Neve Yarak, Israel, Dec. 29, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) ("N2OFF" and the "Company"), a cleantech company investing in solar energy assets based on the RTB (Ready to Build)...
► Artikel lesen
16.12.25N2OFF, Inc. - 8-K, Current Report-
18.11.25N2OFF Inc.: MitoCareX Identifies Hit Compounds and Targets Preclinical Candidate Nomination178Neve Yarak, Israel, Nov. 18, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) ("N2OFF"), a cleantech company investing in solar energy assets based on the RTB (Ready to Build) business model, following...
► Artikel lesen
13.11.25N2OFF, Inc. - 10-Q, Quarterly Report-
N2OFF Aktie jetzt für 0€ handeln
30.10.25N2OFF Inc.: N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers243Neve Yarak, Israel, Oct. 30, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) ("N2OFF" and the "Company"), a cleantech company investing in solar energy assets based on the RTB (Ready to Build)...
► Artikel lesen
23.10.25SciSparc sells majority-owned cancer therapy subsidiary to N2OFF1
23.10.25SciSparc Ltd: SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer243TEL AVIV, Israel, Oct. 23, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...
► Artikel lesen
23.10.25N2OFF, Inc. - 8-K, Current Report1
23.10.25N2OFF schließt Fusion mit Krebstherapie-Spezialist MitoCareX ab3
23.10.25N2OFF Inc.: N2OFF Announces Closing of Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer283Neve Yarak, Israel, Oct. 23, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) ("N2OFF" and the "Company"), a cleantech company investing in solar energy assets based on the RTB (Ready to Build)...
► Artikel lesen
08.10.25N2OFF regains compliance with Nasdaq minimum bid price requirement3
08.10.25N2OFF, Inc. - 8-K, Current Report2
30.09.25SciSparc-Aktie legt kräftig zu: N2OFF-Aktionäre genehmigen Übernahme von MitoCareX3
30.09.25SciSparc stock surges after N2OFF shareholders approve MitoCareX acquisition3
30.09.25SciSparc Stocks Surge 50% In Pre-Market After N2OFF Approves MitoCareX Acquisition3
29.09.25SciSparc's subsidiary MitoCareX approved for acquisition by N2OFF shareholders; shares up 29%3
Weiter >>
47 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1